---
title: "Hyperbaric Oxygen Therapy Did Not Alter Endocannabinoid Markers or LPS After 10 Sessions"
id: "pubmed-43059161"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-43059161"
content_type: "clinical_feed_article"
specialty: "Pulmonology"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/43059161/"
doi: "10.12659/MSM.953923"
published_at: "2026-11-20T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Hyperbaric Oxygen Therapy Did Not Alter Endocannabinoid Markers or LPS After 10 Sessions
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-43059161
- **Specialty:** [Pulmonology](https://medichelpline.com/clinical-feed/pulmonology.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/43059161/)
- **DOI:** [10.12659/MSM.953923](https://doi.org/10.12659%2FMSM.953923)
- **Published At:** 2026-11-20T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- The randomized, exploratory biomarker subanalysis examined serum **anandamide (AEA)** and **lipopolysaccharide (LPS)** as primary outcomes after repeated hyperbaric oxygen therapy (HBOT). - Investigators enrolled a post-randomization, resource-limited sample of 17 healthy, physically active men: 9 assigned to a frequent-treatment HBOT subgroup and 8 controls selected to improve baseline BMI comparability. - The HBOT regimen comprised 10 sessions delivered six times weekly; each session was 60 minutes at 2.5 atmospheres absolute with three 20-minute oxygen-breathing intervals and two 5-minute air breaks. - Fasting serum was collected before and after the 10-session protocol; biomarkers were measured by enzyme-linked immunosorbent assays (ELISA). - No significant between-group differences in change scores were found for **AEA** (p = 0.597), cannabinoid receptor type 2 (CB2R) (p = 1.000), fatty acid amide hydrolase (FAAH) (p = 0.885), or **LPS** (p = 0.885). - The HBOT group showed no significant within-group changes in the measured circulating biomarkers after the intervention. - A baseline positive association between AEA and LPS was observed (Spearman's rho = 0.505, p = 0.039); study authors characterized this as requiring confirmation in adequately powered studies. - Authors noted that the exploratory findings do not exclude smaller effects; the trial was limited by resource constraints and a small, post-randomization sample drawn from select subgroups. - The report did not provide additional methodological details such as power calculations, broader demographic breakdowns, or long-term follow-up beyond immediate pre/post sampling. - Open questions remain about reproducibility in larger, pre-planned cohorts and whether different HBOT dosing regimens or patient populations would yield measurable biomarker changes.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/43059161/#article-details) ### NIH Websites Are Changing * [Get the Latest Updates and FAQs on the transition](https://www.nih.gov/web-modernization) * Per [Executive Order 14434](https://www.whitehouse.gov/presidential-actions/2026/09/inaugurating-the-era-of-super-intelligence/), federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition. ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43059161%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/43059161/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/43059161/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/43059161/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/43059161/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/43059161/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/43059161/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43059161%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43059161%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/43059161/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43059161/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43059161/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/43059161/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43059161/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/43059161/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/43059161/#abstract) * [ Publication types ](https://pubmed.ncbi.nlm.nih.gov/43059161/#publication-types) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/43059161/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/43059161/#substances) Title & authors Abstract Publication types MeSH terms Substances Randomized Controlled Trial Med Sci Monit Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Med+Sci+Monit%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Med+Sci+Monit%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059161/) . 2026 Nov 20:32:e953923. doi: 10.12659/MSM.953923. # A Pilot Investigation of Endocannabinoid System Markers and Lipopolysaccharide Responses to 10 Sessions of Hyperbaric Oxygen Therapy [Jakub Wiącek](https://pubmed.ncbi.nlm.nih.gov/?term=Wi%C4%85cek+J&cauthor_id=43059161)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43059161/#full-view-affiliation-1 "Department of Food and Nutrition, Poznań University of Physical Education, Poznań, Poland."), [Barbara Pospieszna](https://pubmed.ncbi.nlm.nih.gov/?term=Pospieszna+B&cauthor_id=43059161)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43059161/#full-view-affiliation-2 "Department of Athletics, Strength and Conditioning, Poznań University of Physical Education, Poznań, Poland."), [Monika Ciekot-Sołtysiak](https://pubmed.ncbi.nlm.nih.gov/?term=Ciekot-So%C5%82tysiak+M&cauthor_id=43059161)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43059161/#full-view-affiliation-2 "Department of Athletics, Strength and Conditioning, Poznań University of Physical Education, Poznań, Poland."), [Jacek Zieliński](https://pubmed.ncbi.nlm.nih.gov/?term=Zieli%C5%84ski+J&cauthor_id=43059161)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43059161/#full-view-affiliation-2 "Department of Athletics, Strength and Conditioning, Poznań University of Physical Education, Poznań, Poland."), [Krzysztof Kusy](https://pubmed.ncbi.nlm.nih.gov/?term=Kusy+K&cauthor_id=43059161)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43059161/#full-view-affiliation-2 "Department of Athletics, Strength and Conditioning, Poznań University of Physical Education, Poznań, Poland."), [Tomasz Podgórski](https://pubmed.ncbi.nlm.nih.gov/?term=Podg%C3%B3rski+T&cauthor_id=43059161)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/43059161/#full-view-affiliation-3 "Department of Biochemistry, Poznań University of Physical Education, Poznań, Poland."), [Joanna Karolkiewicz](https://pubmed.ncbi.nlm.nih.gov/?term=Karolkiewicz+J&cauthor_id=43059161)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43059161/#full-view-affiliation-1 "Department of Food and Nutrition, Poznań University of Physical Education, Poznań, Poland.") Affiliations Expand ### Affiliations * 1 Department of Food and Nutrition, Poznań University of Physical Education, Poznań, Poland. * 2 Department of Athletics, Strength and Conditioning, Poznań University of Physical Education, Poznań, Poland. * 3 Department of Biochemistry, Poznań University of Physical Education, Poznań, Poland. * PMID: **43059161** * DOI: [ 10.12659/MSM.953923 ](https://doi.org/10.12659/msm.953923) Item in Clipboard Randomized Controlled Trial # A Pilot Investigation of Endocannabinoid System Markers and Lipopolysaccharide Responses to 10 Sessions of Hyperbaric Oxygen Therapy Jakub Wiącek et al. Med Sci Monit. 2026. Show details Display options Display options Format Abstract PubMed PMID Med Sci Monit Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Med+Sci+Monit%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Med+Sci+Monit%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059161/) . 2026 Nov 20:32:e953923. doi: 10.12659/MSM.953923. ### Authors [Jakub Wiącek](https://pubmed.ncbi.nlm.nih.gov/?term=Wi%C4%85cek+J&cauthor_id=43059161)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43059161/#short-view-affiliation-1 "Department of Food and Nutrition, Poznań University of Physical Education, Poznań, Poland."), [Barbara Pospieszna](https://pubmed.ncbi.nlm.nih.gov/?term=Pospieszna+B&cauthor_id=43059161)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43059161/#short-view-affiliation-2 "Department of Athletics, Strength and Conditioning, Poznań University of Physical Education, Poznań, Poland."), [Monika Ciekot-Sołtysiak](https://pubmed.ncbi.nlm.nih.gov/?term=Ciekot-So%C5%82tysiak+M&cauthor_id=43059161)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43059161/#short-view-affiliation-2 "Department of Athletics, Strength and Conditioning, Poznań University of Physical Education, Poznań, Poland."), [Jacek Zieliński](https://pubmed.ncbi.nlm.nih.gov/?term=Zieli%C5%84ski+J&cauthor_id=43059161)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43059161/#short-view-affiliation-2 "Department of Athletics, Strength and Conditioning, Poznań University of Physical Education, Poznań, Poland."), [Krzysztof Kusy](https://pubmed.ncbi.nlm.nih.gov/?term=Kusy+K&cauthor_id=43059161)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43059161/#short-view-affiliation-2 "Department of Athletics, Strength and Conditioning, Poznań University of Physical Education, Poznań, Poland."), [Tomasz Podgórski](https://pubmed.ncbi.nlm.nih.gov/?term=Podg%C3%B3rski+T&cauthor_id=43059161)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/43059161/#short-view-affiliation-3 "Department of Biochemistry, Poznań University of Physical Education, Poznań, Poland."), [Joanna Karolkiewicz](https://pubmed.ncbi.nlm.nih.gov/?term=Karolkiewicz+J&cauthor_id=43059161)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43059161/#short-view-affiliation-1 "Department of Food and Nutrition, Poznań University of Physical Education, Poznań, Poland.") ### Affiliations * 1 Department of Food and Nutrition, Poznań University of Physical Education, Poznań, Poland. * 2 Department of Athletics, Strength and Conditioning, Poznań University of Physical Education, Poznań, Poland. * 3 Department of Biochemistry, Poznań University of Physical Education, Poznań, Poland. * PMID: **43059161** * DOI: [ 10.12659/MSM.953923 ](https://doi.org/10.12659/msm.953923) Item in Clipboard Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract BACKGROUND Hyperbaric oxygen therapy (HBOT) can modulate inflammatory and redox-sensitive pathways, but its effects on endocannabinoid system markers remain unclear. This exploratory biomarker subanalysis of a randomized controlled parent trial evaluated whether repeated HBOT was associated with changes in serum anandamide (AEA) and lipopolysaccharide (LPS) as primary outcomes. Cannabinoid receptor type 2 (CB2R), fatty acid amide hydrolase (FAAH), and the baseline AEA-LPS association were assessed secondarily or exploratorily. MATERIAL AND METHODS The resource-limited, post-randomization sample included 17 healthy, physically active men: 9 from a pre-existing morning scheduling subgroup of the frequent-treatment HBOT arm and 8 controls selected before biomarker assays to improve baseline body mass index (BMI) comparability. HBOT consisted of 10 sessions performed 6 times weekly. Each session involved 60 minutes of 100% oxygen at 2.5 atmospheres absolute, delivered as three 20-min oxygen-breathing periods separated by two 5-minute air breaks. Fasting serum was collected before and after the protocol, and biomarkers were measured using enzyme-linked immunosorbent assays. RESULTS No significant between-group differences in change scores were found for AEA (p = 0.597), CB2R (p=1.000), FAAH (p=0.885), or LPS (p=0.885). No significant within-group changes occurred in the HBOT group. Baseline AEA was positively associated with baseline LPS (Spearman's rho=0.505, p=0.039). CONCLUSIONS Receiving 10 HBOT sessions were not associated with significant changes in the measured circulating biomarkers. These exploratory findings do not exclude smaller effects, and the baseline AEA-LPS association requires confirmation in adequately powered studies. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Publication types * Randomized Controlled Trial Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Randomized+Controlled+Trial%22%5Bpt%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Randomized+Controlled+Trial) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059161/) ## MeSH terms * Adult Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Adult%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Adult) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059161/) * Amidohydrolases / blood Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Amidohydrolases%2Fblood%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Amidohydrolases) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059161/) * Arachidonic Acids / blood Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Arachidonic+Acids%2Fblood%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Arachidonic+Acids) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059161/) * Biomarkers / blood Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Biomarkers%2Fblood%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Biomarkers) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059161/) * Endocannabinoids* / blood Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Endocannabinoids%2Fblood%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Endocannabinoids) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059161/) * Endocannabinoids* / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Endocannabinoids%2Fmetabolism%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Endocannabinoids) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059161/) * Fatty Acid Amide Hydrolases Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Fatty+Acid+Amide+Hydrolases%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Fatty+Acid+Amide+Hydrolases) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059161/) * Humans Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Humans%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Humans) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059161/) * Hyperbaric Oxygenation* / methods Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Hyperbaric+Oxygenation%2Fmethods%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Hyperbaric+Oxygenation) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059161/) * Lipopolysaccharides* / blood Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Lipopolysaccharides%2Fblood%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Lipopolysaccharides) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059161/) * Male Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Male%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Male) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059161/) * Pilot Projects Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Pilot+Projects%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Pilot+Projects) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059161/) * Polyunsaturated Alkamides / blood Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Polyunsaturated+Alkamides%2Fblood%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Polyunsaturated+Alkamides) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059161/) * Receptor, Cannabinoid, CB2 / blood Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Receptor%2C+Cannabinoid%2C+CB2%2Fblood%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Receptor%2C+Cannabinoid%2C+CB2) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059161/) * Receptor, Cannabinoid, CB2 / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Receptor%2C+Cannabinoid%2C+CB2%2Fmetabolism%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Receptor%2C+Cannabinoid%2C+CB2) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059161/) ## Substances * Endocannabinoids Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Endocannabinoids%22%5Bnm%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=%22Endocannabinoids%22) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059161/) * Lipopolysaccharides Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Lipopolysaccharides%22%5Bnm%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=%22Lipopolysaccharides%22) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059161/) * Biomarkers Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Biomarkers%22%5Bnm%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=%22Biomarkers%22) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059161/) * Polyunsaturated Alkamides Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?t
## Related Clinical Research

- [Mavacamten inhibits diaphragm myosin in vitro, with greater potency on slow fibers](https://medichelpline.com/clinical-feed/biorxiv-0-beta-myosin-inhibition-in-skeletal-muscle-impact-of-mavacamten-on-the-diaphragm.md)
- [Dual C5aR1 and C5aR2 loss separates neutrophil influx from antibacterial function in lung infection](https://medichelpline.com/clinical-feed/biorxiv-10-dual-c5ar1-and-c5ar2-deficiency-uncouples-neutrophilic-inflammation-from.md)
- [Expert Disagreement and Ground Truth in Pathology AI: Impact on Clinical Relevance](https://medichelpline.com/clinical-feed/medrxiv-4-beyond-consensus-human-ground-truth-expert-disagreement-and-clinical-relevance.md)
- [Liability-threshold rare-variant test (LTBT) links HTRA3 to idiopathic pulmonary fibrosis](https://medichelpline.com/clinical-feed/medrxiv-9-a-new-liability-based-rare-variant-burden-test-identifies-a-novel-genetic.md)
- [Sugammadex versus Neostigmine for Early Pulmonary Recovery After Thoracoscopic Lung Resection](https://medichelpline.com/clinical-feed/pubmed-43036898.md) (DOI: 10.1080/07853890.2026.2763165)

## Navigation
- [← Back to Pulmonology Feed](https://medichelpline.com/clinical-feed/pulmonology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.